Digital in Pharma

DiME (Digi MarketEr):-TiME to SHiNE

The new sparkling DIME (Digi MarketEr) are the ones who embrace digital transformation with open arms and voraciously feed on data analytics to satisfy their performance outcomes with an informed business decision. The benefit of being DIME is that it propels data management out of the hands of individual stakeholders, and puts data sets with insights on to center glass table (Transparent workplace) for informed decision making.


Digital Therapeutics: New Frontiers in Healthcare

“If we look at major trends, people are living longer, on average, so there’s a rise in chronic diseases associated with aging. Meanwhile, healthcare workers are in short supply, and physicians and nurses do not have enough time for patients. Yet everyone has powerful computers in their pockets that give them access to technology, education, and information. Put all that together, and it’s the perfect moment for digital solutions to come to the market, change behavior, and enhance health outcomes at scale”

– Bozidar Jovicevic, Global head of Digital Therapeutics, Sanofi






DigiStorm 2018: Intent, Content, Strategy and Skills

The pharma industry in India is entering a very interesting variant of the post-digital marketing era. The term “post-digital marketing” is used to depict a state where the lines between physical and digital blur considerably for a customer. However, in the context of pharma, this means a state where the industry has stopped questioning the need for digital and has begun to implement very interesting digital marketing initiatives.




August 2018 Issue

[wpfilebase tag=file id=115 tpl=download-button /] Inside this Issue 1. The ‘Amazonization’ of Healthcare by Salil Kallianpur Amazon’s drive to put the consumer at the center of their market strategy could very well topple well-established incumbents in healthcare. 2. Quality – A Key Issue at OPPI, IPA and IDMA Joint Summit by Vivek Hattangadi…


MENU